Viewing StudyNCT02035072



Ignite Creation Date: 2024-05-06 @ 2:24 AM
Last Modification Date: 2024-10-26 @ 11:17 AM
Study NCT ID: NCT02035072
Status: COMPLETED
Last Update Posted: 2017-07-21
First Post: 2014-01-10

Brief Title: Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer
Sponsor: Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Organization: Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori

Conditions & Keywords Data

Conditions:
Name
Locally Advanced Pancreatic Cancer
Unresectable Pancreatic Cancer
Nonmetastatic Pancreatic Cancer
Keywords: